The recent market research conducted by FMI has opined that the global medical ventilators market is expected to hold a market value of US$ 1.7 billion in 2023. The market is expected to advance at 9.1% between 2023 and 2033. By 2033, the market is projected to cross US$ 4 billion.
Key factors supporting the market growth are:
The outbreak of COVID-19 pandemic led to a number of people suffering from respiratory diseases. It was during this time when the demand for medical ventilator machine exhibited a huge growth. It assisted the patients in breathing when sick, injured, or sedated for an operation. It pumps oxygen-rich air into the lungs, thereby relieving patients from respiratory issues.
The medical ventilator use is rising continuously because oxygen is an important requirement for people suffering from any respiratory disorder. As large number of respiratory diseases are chronic in nature, their treatment requires continuous application of such medical equipment. As per WHO, nearly 3.23 million people died because of chronic obstructive pulmonary disease in 2019, which was the third leading cause of death. The numbers are expected to rise in the coming years. Since majority of those suffering from such chronic disorder might require these medical devices, it is expected that the sales would surge.
The technological advancements in the market are also expected to drive the growth. The researchers have developed Electrical Impedance Tomography (EIT) technique, which assists in defining mechanical ventilation settings. The ability to quantify gains and losses assists in granting a more realistic evaluation of different ventilator modes. The manufacturers are also looking to integrate neural networks and decision tree classification techniques to increase the efficiency of the ventilators. The key players are also looking at ways to improve the mechanical strength of ventilators. In May, 2017, Draegerwerk AG & Co. KGaA launched a robust ventilator “Oxylog VE300”, a sturdy ventilator that can be used for emergency services.
A noteworthy advancement in this industry is the use of microprocessors, which allows the development of advanced signal processing algorithms. This would reduce the fundamental errors in sensor technologies, subsequently cultivating performance.
Development of improved flow measurement technology for a wide range of measurements, robustness to changes in gas composition are some of the key developments. Imposition of a low pneumatic resistance and dead space on the patient, and adequate dynamic response, are surging the market growth.
North America is expected to be the leading region in terms of revenue generation. High disposable income, rising geriatric population, and availability of advanced healthcare infrastructure happen to be the primary factors driving the growth.
| Attributes | Value |
|---|---|
| Medical Ventilators Market Value (2022) | US$ 1.5 billion |
| Medical Ventilators Market Expected Value (2023) | US$ 1.7 billion |
| Medical Ventilators Market Forecast Value (2033) | US$ 4 billion |
| Medical Ventilators Market Expected CAGR (2023 to 2033) | 9.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Surge in chronic respiratory issues and inception of COVID-19 pandemic has increased the adoption of healthcare ventilators. This massive adoption has even led to shortage of medical ventilators in many parts of the world, thereby creating a massive demand supply gap. Surging population has also led to increase in construction activities, which are believed to be one of the leading causes of carbon emissions. Such activities have increased the cases of asthma, COPD, pneumonia, etc., which has ultimately driven the market growth. This can be inferred through statistical comparison as well. While the historical CAGR for the market was 7.3%, the anticipated CAGR is 9.1%.
The market for medical ventilator is highly competitive. After the COVID-19 pandemic, many local players jumped into the business due to rising demand.
In addition, the cost of health ventilators is very high ranging from US$ 1,500 to US$ 72,000, which depends on the type of ventilator. Due to lack of funding, government as well as few private hospitals in low- and middle-income countries cannot afford the high-cost medical ventilators. In addition, the replacement cost of old model ventilators is relatively low in these countries. Therefore, lack of affordability by hospital in low and middle-income countries may deter the growth of the medical ventilators market. This can reduce the sale of the product.
The product recall is very important for public health as it leads to voluntary action of manufacturers and distributors to carry out their responsibility. Being a high involvement product, a common man may not be aware of benefits offered by the ventilators, especially in the developing and underdeveloped nations.
Stringent government regulations are expected to hamper the medical ventilators market growth. In the event of product recall, the company's financial condition, business, and results of operations could be adversely affected which is expected to restrain growth. For instance, in December 2019, Hamilton Medical AG recalled its Hamilton-G5 ventilators due to the “Panel connection lost” error message.
Principal Consultant
| Region | North America |
|---|---|
| Country | United States |
| CAGR (2023 to 2033) | 6.8% |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| CAGR (2023 to 2033) | 5.8% |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR (2023 to 2033) | 14.7% |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR (2023 to 2033) | 9.1% |
| Region | Asia Pacific |
|---|---|
| Country | South Korea |
| CAGR (2023 to 2033) | 8% |
In 2022, the United States accounted for about 90% of the North American medical ventilators market. This is because the manufacturers are focusing to boost up their ventilator manufacturing capacity to meet the rising demand of medical ventilators at hospitals. The increasing number of chronic respiratory disorder patients is believed to be the key factor.
| Attributes | Details |
|---|---|
| United States Market Expected Size (2033) | US$ 777.8 million |
| United States Market Absolute Dollar Growth | US$ 375.8 million |
| CAGR % 2017 to 2022 | 3.9% |
In addition, the use of ventilators increased during the COVID-19 pandemic. To fulfill the increasing demand of ventilators, FDA gave Emergency Use Authorization (EUA). Increasing requirement has given the United States market a significant boost, with prospects looking positive through 2023 and beyond.
The United Kingdom accounted for around 21% of the European market in 2022. The leading cause of increased demand for medical ventilators in the United Kingdom is the large number of people infected with coronavirus during the first and second wave. United Kingdom is also home to one of the largest number of patients suffering from Alzheimer’s disease, which propels the sales of medical ventilators.
| Attributes | Details |
|---|---|
| United Kingdom Market Expected Size (2033) | US$ 78.2 million |
| United Kingdom Market Absolute Dollar Growth | US$ 33.7 million |
| CAGR % 2017 to 2022 | 3.5% |
Additionally, one of the key causes driving demand for medical ventilators in the region is the increased frequency of chronic and respiratory illnesses. The presence of major manufacturers has also propelled the market growth. and increased technology and innovations related activities in ventilators taking place.
China accounted for around 30% of the East Asia market in 2022. The surging healthcare spending, better medical facilities, an increase in the geriatric population are the key factors driving growth. Presence of large number of local ventilator manufacturing players and a rising economic growth rate are also driving the market expansion.
| Attributes | Details |
|---|---|
| China Market Expected Size (2033) | US$ 366 million |
| China Market Absolute Dollar Growth | US$ 273 million |
| CAGR % 2017 to 2022 | 13.8% |
In the Chinese market, regional manufacturers have gained lots of traction. Beijing Aeonmed Co Ltd and Shenzhen Mindray Bio-Medical Electronics Co Ltd are two notable players who are fulfilling the market demand in the country.
Japan is meant to have the highest geriatric population by percentage. Based on latest research, nearly 30% of the Japanese population is above the age of 65. A lot many of them suffer from cerebrovascular issues, cardiac disease, etc. Many of them need to be under ventilator as a precautionary measure, as the oxygen level comes down, and the ventilators support in inhaling oxygen.
| Attributes | Details |
|---|---|
| Japan Market Expected Size (2033) | US$ 354.2 million |
| Japan Market Absolute Dollar Growth | US$ 206.5 million |
| CAGR % 2017 to 2022 | 9.4% |
Moreover, the presence of a lot of key players in Japan is also expected to drive the market growth. This ensures that owing to local manufacturing capabilities, the cost would also come down.
South Korea is meant for its technologically advanced and sophisticated healthcare market. As of 2020, the South Korea market was valued at US$ 144.2 billion, and the market is expected to grow at 24.3%. This gives room for the adoption of medical ventilators in large numbers. The availability of microprocessor-controlled ventilator integrated with new modes is expected to further drive the market growth.
| Attributes | Details |
|---|---|
| South Korea Market Expected Size (2033) | US$ 91.5 million |
| South Korea Market Absolute Dollar Growth | US$ 49.1 million |
| CAGR % 2017 to 2022 | 5.5% |
Furthermore, the researchers have also developed easy to assemble and portable ventilators, which are low cost as well. During the pandemic, these were highly sought-after, as a lot of people got affected, and the country was running short of ventilators.
| Segment | Product Type |
|---|---|
| Attribute | Critical Care Ventilators |
| CAGR (2017 to 2022) | 6.9% |
| CAGR (2023 to 2033) | 8.6% |
| Segment | Application |
|---|---|
| Attribute | Invasive Ventilators |
| CAGR (2017 to 2022) | 5.7% |
| CAGR (2023 to 2033) | 7.5% |
Critical care ventilators are predicted to be on the spotlight, owing to the rising number of patients requiring critical care for a variety of respiratory and cardiac disorders. They held the largest market share of 88% in 2022. The main advantage of employing critical care ventilators is that these do not require much of human interference.
As governments spending on healthcare infrastructure increased, the number of hospitals and clinics also increased, resulting in a recent boom in demand for critical care ventilators. Even during COVID-19, the demand for ventilators was extremely high.
By application, the invasive ventilators segment is anticipated to hold the maximum share of 61% in 2023. Invasive ventilators are used widely in treatment of those with acute exacerbations of COPD on several levels, including length of stay, hospital-acquired pneumonia, and mortality.
Comatose intubated patients who are under the influence of anesthesia tolerate invasive ventilation quite well. Patients can be invasively ventilated while being comfortable under little or no sedation. The invasive ventilators help patients with hypoxemic and hypercapnic respiratory failure, and allows for the implementation of lung-protective ventilation.
By end user, hospital hold over 52% of the market in 2021 and this trend is expected to continue during the forecast period as well. This is predominantly seen due to the large number of patients admitted into the hospital for seeking treatment for various diseases including respiratory infections and COVID-19.
While floating a tender, the hospitals generally buy such devices in bulk. Apart from that, because of the admission of patients on frequent basis, the hospitals may purchase the ventilators regularly.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The start-ups have been developing economical ventilator which run on room air without the need for compressed medical air. The machine delivers a 100% fraction of inspired oxygen when connected to an oxygen source. It is controlled by capacitive multi-touch interface. The ventilator is also enhanced with gesture control interface, which works without any need for training.
ABM Respiratory Care: The start-up has been developing ventilation solutions for people suffering from pulmonary diseases. The ‘Alpha Ventilator’ developed by the start-up is an internet-enabled ventilator for remote ventilation. The turbine technology used by the start-up implements several therapy modes for invasive and non-invasive ventilation. In October 2020, ABM Respiratory Care raised US$ 10.3 million in the Series A funding.
The manufacturers operating in the medical ventilators market look to automate healthcare processes. This is being done either by the introduction of robots or through track-based configuration options that are designed to eliminate the manual sorting of plates. This helps in ensuring culture integrity and results in streamlined workflow. In January 2023, Becton, Dickinson, and Company introduced fully automated robotics track system for microbiology labs.
Key developments in the market are:
Top players in the market:
| Company | Cardinal Health |
|---|---|
| Description | Cardinal Health brings scaled solution to the healthcare sector to help their customers live in a thriving world. The company distributes pharmaceuticals, manufactures and distributes medical and laboratory products. The company has also been providing performance and data solutions for healthcare facilities. Cardinal Health is a crucial link between the clinical and operational sides of healthcare, delivering end to end solutions, and data driven insights. With more than five decades of experience, the company seizes the opportunity to address healthcare’s most complicated challenges – now, and in the future. |
| Company | Becton Dickinson and Company |
|---|---|
| Description | Becton Dickinson and Company is one of the world’s largest global medical technology companies and is advancing the world of healthTM by improving medical discovery. The company supports the heroes on the frontlines of healthcare by developing innovative technologies and solutions. With a headcount of more than 75,000, the company has a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process and enable laboratory scientists to detect disease. BD also helps enhance outcomes, lower the costs and increase efficiencies. |
| Company | GE Healthcare |
|---|---|
| Description | GE Healthcare is the leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. The company enables physicians to make faster, more informed decisions through intelligent devices, data analytics, applications, and services. GE Healthcare is committed to foster an inclusive culture of respect, transparency, and unyielding integrity. With presence in over 160 countries, and employing more than 47,000 workers, the company has been making a massive impact in the healthcare sector over the years. |
Other significant companies profiled: Koninklijke Philips N.V., Draegerwerk AG & Co. KGaA
The market will expand at a 9.1% CAGR from 2023 to 2033.
The market in 2023 totals US$ 1.7 billion.
North America is expected to be a lucrative market.
Supply chain disruptions and regulatory challenges limit market growth.
From 2017 to 2021, the market rose at a 7.3% CAGR.
1. Executive Summary | Medical Ventilators Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Critical Care Ventilators
5.3.2. Transport Ventilators
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Invasive Ventilators
6.3.2. Non-Invasive Ventilator
6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Long Term Care Centers
7.3.4. Home Care Settings
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. United Kingdom (UK)
11.2.1.2. Germany
11.2.1.3. France
11.2.1.4. Italy
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. Rest of Europe
11.2.2. By Product Type
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product Type
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Indonesia
13.2.1.3. Thailand
13.2.1.4. Malaysia
13.2.1.5. Rest of South Asia
13.2.2. By Product Type
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. South Africa
15.2.1.2. Turkey
15.2.1.3. GCC Countries
15.2.1.4. Rest of Middle East and Africa
15.2.2. By Product Type
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Application
16.5.2.3. By End User
16.6. Chile
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Application
16.6.2.3. By End User
16.7. EU-4
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Application
16.7.2.3. By End User
16.8. UK
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Application
16.8.2.3. By End User
16.9. BENELUX
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Nordic
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Application
16.11.2.3. By End User
16.12. China
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Japan
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Application
16.13.2.3. By End User
16.14. South Korea
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Application
16.14.2.3. By End User
16.15. India
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Application
16.15.2.3. By End User
16.16. ASEAN
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Application
16.16.2.3. By End User
16.17. Australia & New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Application
16.17.2.3. By End User
16.18. GCC Countries
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Application
16.18.2.3. By End User
16.19. South Africa
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Application
16.19.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Becton Dickinson and Company,
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Cardinal Health
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. GE Healthcare
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Koninklijke Philips N.V.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Draegerwerk AG & Co. KGaA,
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Medtronic Plc.,
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Getinge AB,
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Hamilton Medical AG,
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Smiths Medical,
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Fisher & Paykel Healthcare,
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Bunnell Incorporated
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Medical Ventilators Market
